Why Precision-focused Healthcare Matters
November 23, 2022
HALO is improving patient outcomes and saving more lives with early detection, driven by our precision diagnostics ensemble.
precision diagnostics Info & Updates
What are Cancer-Causing Genetic Mutations and What Do They Mean to Me?
November 21, 2022
Understanding the resources available to you after a cancer diagnosis can help you with navigating your mental and physical health.
Why Multiomics is Healthcare’s Next Big Step
September 21, 2022
Healthcare experts like Dr. Chris Hancock are leveraging multiomics to take a proactive approach to detecting diseases sooner.
How MRI & Genomics Could Prevent 1 in 6 Prostate Cancer Deaths
March 17, 2021
A new study suggests that screening for prostate cancer using genetic testing and a multiparametric MRI (mpMRI) scan before an invasive biopsy could prevent as many as 1 in 6 deaths from the disease and significantly reduce over-diagnosis and unnecessary treatment.[i] Researchers at the University College of London modeled the
Biomarkers and Genomics in Prostate Cancer Diagnostics and Treatment
September 24, 2020
Biomarker, genetic, and genomic testing offer men new insights into their prostate health and help choose the best course of action.
